Increasing evidence suggests that the activities of low molecular weight (LMW) oligomers, formed during the early stages of tau aggregation, most likely associate with neurotoxicity that leads to AD [[6], [7], [8]]. The gene discussed is MAPT; the disease is Alzheimer disease.